Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-25

FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for the carbidopa/levodopa/entacapone combination by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa, Levodopa and Entacapone (carbidopa/levodopa/entacapone)

Snippet

SUPPL AP for CARBIDOPA, LEVODOPA, AND ENTACAPONE (CARBIDOPA, LEVODOPA, AND ENTACAPONE)